Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiotensin II for the Treatment of Vasodilatory Shock.
Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, Busse LW, Altaweel L, Albertson TE, Mackey C, McCurdy MT, Boldt DW, Chock S, Young PJ, Krell K, Wunderink RG, Ostermann M, Murugan R, Gong MN, Panwar R, Hästbacka J, Favory R, Venkatesh B, Thompson BT, Bellomo R, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Deane AM; ATHOS-3 Investigators. Khanna A, et al. Among authors: ostermann m. N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154. Epub 2017 May 21. N Engl J Med. 2017. PMID: 28528561 Free article. Clinical Trial.
Angiotensin II for the Treatment of Vasodilatory Shock.
Khanna A, Ostermann M, Bellomo R. Khanna A, et al. Among authors: ostermann m. N Engl J Med. 2017 Dec 28;377(26):2604. doi: 10.1056/NEJMc1714511. N Engl J Med. 2017. PMID: 29281568 No abstract available.
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, Kashani K, Szerlip HM, Prowle JR, Bihorac A, Finkel KW, Zarbock A, Forni LG, Lynch SJ, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Bellomo R; Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators. Tumlin JA, et al. Among authors: ostermann m. Crit Care Med. 2018 Jun;46(6):949-957. doi: 10.1097/CCM.0000000000003092. Crit Care Med. 2018. PMID: 29509568 Free PMC article.
Angiotensin in Critical Care.
Hall A, Busse LW, Ostermann M. Hall A, et al. Among authors: ostermann m. Crit Care. 2018 Mar 20;22(1):69. doi: 10.1186/s13054-018-1995-z. Crit Care. 2018. PMID: 29558991 Free PMC article. Review.
Angiotensin in ECMO patients with refractory shock.
Ostermann M, Boldt DW, Harper MD, Lim GW, Gunnerson K. Ostermann M, et al. Crit Care. 2018 Nov 1;22(1):288. doi: 10.1186/s13054-018-2225-4. Crit Care. 2018. PMID: 30382926 Free PMC article. No abstract available.
Challenges in the management of septic shock: a narrative review.
De Backer D, Cecconi M, Lipman J, Machado F, Myatra SN, Ostermann M, Perner A, Teboul JL, Vincent JL, Walley KR. De Backer D, et al. Among authors: ostermann m. Intensive Care Med. 2019 Apr;45(4):420-433. doi: 10.1007/s00134-019-05544-x. Epub 2019 Feb 11. Intensive Care Med. 2019. PMID: 30741328 Review.
508 results